-
1 week ago | 
patientcareonline.com | Brad P. Glick |Grace Halsey
At Revolutionizing Atopic Dermatitis 2025, the annual meeting focused on advances in management of the pruritic skin condition, Brad Glick, DO, MPH, and colleagues presented a session titled, Understanding Topical Steroid Withdrawal (TSW) in Patients with Atopic Dermatitis.
-
1 week ago | 
patientcareonline.com | Brad P. Glick |Grace Halsey
Topical corticosteroid withdrawal, which is also known as red skin syndrome or topical steroid addiction, is a drug-related dermatosis that erupts following sudden cessation of medium- to high-potency topical corticosteroids.
-
2 weeks ago | 
dermatologytimes.com | Brad P. Glick |Kaitlyn Bader
“We need to be on the lookout for topical steroid withdrawal. As my colleague Peter Lio always says, it's sometimes very difficult to differentiate it from a really bad flare of atopic dermatitis, but you have to take a step back. You have to get a really good history. You have to talk about whether patients are following the instructions with the use of topical corticosteroids,” said Brad Glick, DO, MPH, in an interview with Dermatology Times.
-
Jan 6, 2025 | 
consultantlive.com | Brad P. Glick
-
Oct 3, 2024 | 
dermatologytimes.com | Brad P. Glick
October 3, 2024By Brad Glick, DO, MPH, discusses how to effectively introduce photodynamic therapy (PDT) into a dermatology clinic by outlining necessary equipment and setup, providing guidance on essential patient discussions for treatment introduction, and sharing strategies to ensure treatment efficacy while prioritizing patient safety and satisfaction.
-
Oct 3, 2024 | 
dermatologytimes.com | Brad P. Glick
Brad Glick, DO, MPH, discusses how photodynamic therapy (PDT) serves as an effective treatment for various skin conditions, highlighting the specific patient populations that are most likely to benefit from this innovative approach.
-
Oct 3, 2024 | 
dermatologytimes.com | Brad P. Glick
October 3, 2024By Brad Glick, DO, MPH, discusses common challenges clinicians may encounter with photodynamic therapy (PDT) and offers resolution strategies, while also sharing insights on the skin conditions and patient populations where PDT has proven to be a successful treatment option. Video content above is prompted by the following:What are a couple of common challenges clinicians can expect to face with PDT and how can they resolve them?
-
Apr 1, 2024 | 
dermatologytimes.com | Brad P. Glick
In the Dermatology Times Expert Perspectives series "Advancements in Atopic Dermatitis: Insights from the 2024 Masterclasses in Dermatology Conference," leading dermatologists discuss the advancements in treatments and data for atopic dermatitis (AD) with hand-foot involvement, diversity in clinical trials, and pearls from the American Academy of Dermatology's (AAD) AD treatment guidelines.
-
Apr 1, 2024 | 
dermatologytimes.com | Brad P. Glick
In the Dermatology Times Expert Perspectives series "Advancements in Atopic Dermatitis: Insights from the 2024 Masterclasses in Dermatology Conference," leading dermatologists discuss the advancements in treatments and data for atopic dermatitis (AD) with hand-foot involvement, diversity in clinical trials, and pearls from the American Academy of Dermatology's (AAD) AD treatment guidelines.
-
Jun 20, 2023 | 
dermatologytimes.com | Jonathan I. Silverberg |Brad P. Glick |Andrew Blauvelt |Elizabeth Swanson
Jonathan I Silverberg, MD, PhD, MPH: We have time to cover our last case and that is a 32-year-old male, so now we've gotten into the adult realm. He has had atopic dermatitis since school age which has worsened over the past 5 years. He’s experienced a lot of flare-ups in the past year that are getting better with the use of a lot of topical steroids and sometimes oral steroids, but then everything flares-up again within a few days; such a classic scenario of completing those treatments.
